Prostaglandins (PGs) interact with specific receptors on plasma membranes to regulate myometrial activity in many species. The present study examined whether the expression of relaxant prostaglandin E receptor subtype two (EP 2 ) and contractile prostaglandin F receptor (FP) mRNA in the rat uterus is changed during various states of pregnancy and regulated by steroid hormones. Expression of mRNA for EP 2 and FP receptors in the fullthickness uteri was analyzed by reverse transcription-polymerase chain reaction using specific primers. Abundance of receptor mRNA was expressed relative to ␤-actin mRNA. Results showed that 1) mRNA for EP 2 receptors in the rat uterus was substantially increased during pregnancy (320%) compared with the nonpregnant state (100%, P Ͻ 0.01), and declined during labor at term (36% vs. 100% in control, P Ͻ 0.01); 2) mRNA expression for FP receptors in rat uterus was increased during pregnancy (333% vs. 100% in nonpregnant rats, P Ͻ 0.01) and reached maximal levels during labor (515% vs. 100% in control, P Ͻ 0.01); 3) upon RU-486 treatment on Day 19 of pregnancy, uterine EP 2 receptor mRNA levels were decreased (18% vs. 100% in control, P Ͻ 0.01), and FP mRNA levels were increased (357% vs. 100% in control, P Ͻ 0.01); 4) with ICI 164384 (an antiestrogen) treatment on Day 19 of gestation, uterine FP receptor mRNA levels were decreased without effects on EP 2 receptors; 5) in ovariectomized (ovx) rats, progesterone increased EP 2 (163% vs. 100% in control, P Ͻ 0.01) and had no effects on FP receptor mRNA expression in the rat uterus; 6) estradiol increased FP receptor mRNA levels (358% vs. 100% in control, P Ͻ 0.01) and had no effects on EP 2 mRNA in the ovx rat uterus. Therefore, we conclude that steroid hormones modulate the mRNA for relaxant EP 2 and contractile FP receptors for PGs in the uterus and thus regulate uterine activity during pregnancy and labor.
INTRODUCTION
Prostanoids play a physiological role in the regulation of uterine activity in a number of species [1] . Levels of prostaglandins (PGs) and their metabolites rise sharply in amniotic fluid and maternal plasma during labor [2] . PGs are capable of stimulating myometrial contraction and can cause cervical softening and dilatation [3] . Exogenously administered PGs can terminate pregnancy [3] , and inhibitors of PG synthesis extend the period of gestation and delay preterm parturition [4] . However, wide use of prostanoids is limited by a high incidence of side effects. Side effects can be reduced by the development of drugs that have a selective action targeting specific PG receptors by mediating the beneficial, but not the deleterious, effects.
Pharmacological approaches have suggested the existence of a variety of prostanoid receptors. Based on functional criteria using natural PGs and selective agonists and antagonists, a classification of different subtypes of receptors has been suggested [5, 6] . Prostanoid receptors comprise five major subtypes, including DP, FP, IP, TP, and EP receptors named in accordance with their selectivity for the natural prostanoids, PGD 2 , PGF 2␣ , PGI 2 , TXA 2 , and PGE 2 , respectively [7] . The EP receptor is further subdivided into EP 1 , EP 2 , EP 3 , and EP 4 subtypes according to their differential affinities for some relatively selective agonists [7, 8] .
The effects associated with EP 2 receptors are considered relaxant and are believed to be associated with a stimulation of adenylate cyclase and an increase in the levels of intracellular cAMP [9] . EP 2 receptors have been identified in vascular, gastrointestinal, tracheal, and uterine smooth muscle from various species; these receptors may mediate the relaxation of trachea and ileum circular muscles and the vasodilation of various blood vessels [9] . The contractile FP receptors mediate calcium mobilization and induce smooth muscle contraction [10] . FP receptors appear to modulate uterine contractions with the utilization of the phospholipase pathway in nonpregnant and pregnant rat myometrium [11] . Rat myometrium demonstrated a different pattern of response to PGF 2␣ and PGE 2 [12] . In human myometrium taken either during the menstrual cycle, during pregnancy, or during labor at term, PGE as well as PGF 2␣ receptor concentrations were highest in the fundus and decreased toward the cervix [13] . Further, the affinity of the PGF receptor for its ligand was 10-20 times lower than that of the PGE 2 receptor, and the potency of PGE 2 in relaxing the cervix was greater than that of PGF 2␣ [13] , suggesting that these PGs act at different sites in the myometrium and that differential expression of these PG receptor isoforms may ultimately determine tissue response.
Recent molecular cloning approaches unequivocally revealed the existence of these receptors in the rat and mouse uterus [14, 15] , and these receptors have different molecular and biochemical properties [16, 17] . These findings suggest that the exquisite and diverse actions of prostanoids are based on the existence of functionally different prostanoid receptors and their isoforms. In this study, we determined the expression of the relaxant EP 2 and contractile FP receptor in the uterus of rats in the nonpregnant state, during pregnancy, during labor, and postpartum. Further, we examined whether the expression of these EP 2 and FP receptors in the rat uterus is regulated by changes in ovarian steroid hormones.
MATERIALS AND METHODS

Animals and Treatments
Adult nonpregnant (180-200 g BW) and pregnant Sprague-Dawley rats were purchased from Harlan-Sprague Dawley (Houston, TX) and maintained on a 12L:12D schedule. Animals received an ad libitum supply of rat chow and water. Three experiments were performed. In experiment 1, we examined the changes in EP 2 and FP receptor mRNA levels in the uterus of rats in the nonpregnant state, during pregnancy, during labor, and postpartum. In experiment 2, we observed the regulation of uterine EP 2 and FP receptor mRNA expression during pregnancy by antiestrogen (ICI 164384) and antiprogesterone (RU-486). In experiment 3, we determined the influences of estrogen and progesterone administration on EP 2 and FP receptor mRNA expression in ovariectomized rats. These investigations were conducted in accordance with the Guiding Principles for the Care and Use of Research Animals promulgated by the Society for the Study of Reproduction. Experiment 1. Uterine tissues were obtained from four rats in each group of nonpregnant animals at diestrus and in each group of time-mated rats on Day 18 of gestation (Day 1 of gestation was the day of a sperm-positive vaginal smear; normal duration of gestation for rats is 22 days), at the time of spontaneous delivery at term (1-3 pups delivered), or on Day 1 postpartum. Animals were killed in a CO 2 inhalation chamber. The uteri were removed immediately; they were cleaned of fat, placenta, fetuses, and fetal membranes and rinsed thoroughly in ice-cold PBS (10 mM, pH 7.4). In some experiments, the endometrial tissues were removed by gentle scraping using a blunted scalpel while the uterine tissue was held on a chilled (ice-cold) glass plate [18] . The remaining myometrial tissue or the full-thickness uterus from the antimesometrial area was quickly frozen in liquid nitrogen and stored at Ϫ70ЊC until used. All procedures were approved by the Animal Care and Use Committee of the University of Texas Medical Branch. Cheshire, UK) or an antiprogesterone (RU-486; 10 mg/rat; Biomol, Plymouth Meeting, PA). The animals (four rats in each group) were killed 24 h after injection. The full-thickness uteri from the antimesometrial area were frozen in liquid nitrogen as indicated above.
Experiment 3. Sixteen female rats were randomly distributed into four experimental groups. Seven days after being ovariectomized (ovx), the rats were injected s.c. with either estradiol-17␤ (5 g/rat), progesterone (4 mg/rat), or estradiol-17␤ plus progesterone in 0.2 ml sesame oil or oil alone. The animals were killed 24 h after injection. The full-thickness uteri were removed and frozen in liquid nitrogen for further analysis.
Polymerase Chain Reaction (PCR) Analysis of PG Receptor Isoforms
Total cellular RNA was extracted from the rat uterus by a single-step guanidine thiocyanate method [19] using the reagent Trizol (Gibco/BRL Life Technologies, Gaithersburg, MD). First-strand cDNA synthesis was primed with oligodeoxythymidine using 2 g of total extranuclear RNA with 10 U of reverse transcriptase and oligodeoxythymidine 12-18 (Gibco/BRL Life Technologies) as primer in a total volume of 20 l at 42ЊC for 40 min, as described previously [20] . Ten percent of the cDNA made from 2 g total RNA was used for amplification by PCR with 35 cycles as previously reported [20] . PCR primers used in the current study were derived from the published sequences of mouse EP 2 receptor [21, 22] , rat FP receptor [23, 24] , and rat ␤-actin [25] . The specific primers used for amplification were as follows: 1) EP 2 receptor: forward primer 5Ј-CCCTGCAGCGCCTCAGCGACTTT-3Ј, reverse primer 5Ј-CCTGCCTCCTAGGCTGCTTTCAGT-3Ј (with an expected length of 490 base pairs [bp]); 2) FP receptor: forward primer 5Ј-TCATCGCCAACACGACTTGC-3Ј, reverse primer 5Ј-ATGTTCACTCCACAGCAGCG-3Ј (with an expected length of 1015 bp); 3) ␤-actin: forward primer 5Ј-GTCGACAACGGCTCCGGCA-3Ј, reverse primer 5Ј-GTCAGGTCCCGGCCAGCCA-3Ј (with an expected length of 530 bp). PCR products, with use of these primers, were identical to those of published sequences as confirmed by direct double-strand sequencing (Fmol DNA sequencing kit; Promega, Madison, WI; data not shown).
In preliminary experiments, we optimized the amount of RNA subject to reverse transcription-PCR (RT-PCR) as well as the number of cycles for PCR [26] . Representative data from one set of experiments for EP 2 and FP are presented in Figure 1 Top) RT-PCR of samples with EP 2 receptor and ␤-actin primers. Oil: Uterus from ovx rats given sesame oil as control; E: uterus from ovx rats given estradiol-17␤ (5 g/rat); P: uterus from ovx rats given progesterone (4 mg/ rat); EϩP: uterus from ovx rats given both estradiol-17␤ (5 g/rat) and progesterone (4 mg/rat). Bottom) Relative levels of EP 2 receptor are presented as ratio of readings of corresponding ␤-actin samples. Asterisk indicates significant difference vs. Oil (P Ͻ 0.01, ANOVA). 
Quantitation of cDNA
The relative concentrations of EP 2 , FP, and ␤-actin mRNA were determined by densitometric analysis of photographs of the ethidium bromide-stained reaction products using Sigma Gel Analysis System (SPSS Inc., Chicago, IL). The results are expressed as the ratio of the densitometric readings for EP 2 and FP receptor mRNA to housekeeping gene ␤-actin mRNA, and therefore the results indicate relative changes in uterine EP 2 and FP receptor mRNA levels.
Statistics
Results are expressed as mean Ϯ SEM. Data were analyzed for statistical differences by one-way ANOVA followed by Bonferroni t-test or Student's t-test. Differences were considered significant if P Ͻ 0.05.
RESULTS
EP 2 Receptor Expression in the Rat Uterus
Messenger RNA expression for EP 2 receptors in the uterus was determined in nonpregnant rats at diestrous stage and in pregnant rats on Day 18 of gestation, during labor, and postpartum (Fig. 2) . Expression of EP 2 receptor mRNA was substantially increased in the rat uterus during pregnancy (320%) compared with nonpregnancy (100%, P Ͻ 0.01). The expression of EP 2 receptor mRNA during labor at term and at 1 day postpartum declined significantly compared with that during pregnancy (36% and 19% vs. 100% in pregnancy, P Ͻ 0.01). These data indicate that the expression of relaxant EP 2 receptor in the rat uterus is minimal in the nonpregnant state, up-regulated during pregnancy, and down-regulated during term labor and postpartum.
To assess whether endogenous estradiol and progesterone play a role in EP 2 receptor mRNA expression in the uterus during pregnancy, we measured EP 2 receptor mRNA in the uterus from pregnant rats treated with an antiestrogen, ICI 164384, and an antiprogesterone, RU-486 (Fig. 3) . Treatment with ICI 164384 on Day 19 of gestation did not significantly change EP 2 receptor mRNA levels in the rat uterus. However, all rats given RU-486 delivered pups within 24 h after injection as reported previously [26] . Further, RU-486-induced preterm labor was associated with a profound decline in EP 2 mRNA expression (18% vs. 100% in control, P Ͻ 0.01). These observations suggest that endogenous progesterone is required, but not estrogens, for maintaining EP 2 receptor mRNA expression during pregnancy.
To examine the effects of estrogens and progesterone on EP 2 receptor mRNA expression in the nonpregnant rat uterus, we measured the relative changes of EP 2 receptor mRNA in ovx rats given estradiol-17␤ or progesterone (Fig. 4) . Expression of EP 2 receptor mRNA was increased significantly by progesterone or progesterone plus estradiol- RT-PCR of samples with FP receptor and ␤-actin primers. Oil: Uterus from ovx rats given sesame oil as control; E: uterus from ovx rats given estradiol-17␤ (5 g/rat); P: uterus from ovx rats given progesterone (4 mg/rat); EϩP: uterus from the ovx rats given both estradiol-17␤ (5 g/rat) and progesterone (4 mg/rat). Bottom) Relative levels of FP receptor mRNA. Asterisk indicates significant difference vs. Oil (P Ͻ 0.01, ANOVA).
17␤ (163% and 225%, respectively, vs. 100% in control, P Ͻ 0.01), but no significant changes were observed with estradiol-17␤ alone, confirming the stimulatory effects of progesterone on EP 2 receptor mRNA expression. In addition, the rise in EP 2 receptor expression in the estradiol-17␤ plus progesterone group was greater than in the progesterone group (P Ͻ 0.05, ANOVA).
FP Receptor Expression in Rat Uterus
Messenger RNA expression for FP receptors in the uterus was determined in nonpregnant rats at diestrus and in pregnant rats on Day 18 of gestation, during labor, and postpartum (Fig. 5) . Expression of FP receptor mRNA in the rat uterus was significantly increased during pregnancy (333% vs. 100% in nonpregnant rats, P Ͻ 0.01), reached maximal levels during labor at term (515% vs. 100% in nonpregnant rats, P Ͻ 0.01), and returned to low levels at postpartum that were similar to those in nonpregnant rats.
Expression of FP receptor mRNA was measured in the uterus from pregnant rats treated with ICI 164384 and RU-486 (Fig. 6) . FP receptor mRNA expression in the uterus was reduced by ICI 164384 administration to Day 19 pregnant rats (38% vs. 100% in control, P Ͻ 0.05). Upon RU-486 treatment on Day 19 of pregnancy, uterine FP receptor mRNA levels were substantially increased (357% vs. 100% in Day 20 pregnant control, P Ͻ 0.01), suggesting that both progesterone and estrogens are involved in the regulation of FP receptor mRNA expression in the pregnant rat uterus.
Expression of FP receptor mRNA was also measured in ovx rats given estradiol-17␤ or progesterone (Fig. 7) . Expression of FP receptor mRNA was significantly increased by estradiol-17␤ (358% vs. 100% in control, P Ͻ 0.01) and was dampened by combined treatment with progesterone in comparison to treatment with estradiol-17␤ alone (217% vs. 100% in control, P Ͻ 0.01). The FP receptor mRNA with combined treatment was significantly higher than with oilonly treatment. However, no significant changes were observed with progesterone alone, confirming the stimulatory effects of estradiol-17␤ on uterine FP receptor mRNA expression.
Comparison of EP 2 and FP Receptor mRNA Expression in the Rat Full-Thickness Uterus and Myometrium
To examine the distribution and regulation of EP 2 and FP receptors in rat uterus, we measured the relative changes of EP 2 and FP receptor mRNA both in full-thickness uterus and in isolated myometrium after removal of endometrium. Figure 8 shows a similar pattern of EP 2 and FP receptor expression in the full-thickness uterine tissues and isolated myometrium in all treatment groups, indicating that changes in these receptors in myometrium are similar to those in the full-thickness uterus. 
DISCUSSION
The present studies demonstrated that 1) mRNA for EP 2 receptors in the rat uterus was increased during pregnancy as compared with the nonpregnant state and declined during labor and postpartum; 2) mRNA for FP receptors was increased in the rat uterus during pregnancy and reached maximal levels during labor; 3) antiprogesterone RU-486 inhibited the expression of EP 2 mRNA and stimulated the expression of FP mRNA in the pregnant rat uterus; 4) antiestrogen ICI 164384 suppressed the expression of FP mRNA without effects on EP 2 mRNA expression; 5) in ovx rats, progesterone increased EP 2 mRNA expression, while estradiol-17␤ increased FP mRNA expression. Thus, the expression of relaxant EP 2 receptors in the rat uterus increases with pregnancy and decreases with labor, and appeared to be progesterone dependent. The contractile FP receptor, on the other hand, is maximal at term labor and appeared to be estrogen dependent. Therefore, steroid hormones modulate the uterine EP 2 and FP receptors for PGs, and the changes in expression of relaxant and contractile receptors may participate in both maintenance of uterine quiescence during pregnancy and the switch to contractions for labor. PGE 2 is a major metabolite of arachidonic acid synthesized by the cyclooxygenase pathway in the amnion and decidua of the uterus [27] . PGE 2 regulates uterine functions such as contraction and relaxation of the uterine smooth muscles, decidualization, cervical ripening, and the induction of labor [3] . These actions of PGE 2 are exerted through its binding to specific receptors on plasma membranes. Two PGE 2 receptors exist in the reproductive tract: high-affinity sites in the myometrium and low-affinity sites in the cervix [28] . However, the lack of receptor specificity of the natural prostanoids renders the interpretation of these binding studies difficult. The present study provides evidence for the existence of relaxant EP 2 receptors in the rat uterus, and the expression of EP 2 receptors in the rat uterus varies with reproductive state or hormonal treatment of the animals. The mRNA encoding EP 2 , which is coupled to the relaxant action through an adenylate cyclase, was expressed in the rat uterus, and its levels increased during pregnancy and decreased during labor. These observations are consistent with recent findings [14] showing that, in the rat myometrium, the EP 2 receptors are abundant during pregnancy and decline at term, while FP receptors are maximal at term labor. The remarkable increase of EP 2 mRNA expression in the rat uterus during pregnancy and its profound decrease during labor suggest that PGE 2 may be involved in the maintenance of uterine quiescence via activation of EP 2 receptor subtype.
PGF 2␣ produces constriction of bronchia, trachea, stomach fundus, and lung strips and of vascular and nonvascular smooth muscle preparations [9] . Measurements of PGF 2␣ in the uterine vein of pregnant rats demonstrated that its concentrations increased gradually from Day 15 of gestation, with the highest concentration occurring around the time of delivery [29] . The production of PGF 2␣ was 3-5 times higher than that of PGE 2 in the uterus over the last 4 days of gestation in the pregnant rat [30] . The present study provides evidence that the mRNA encoding FP was increased in the pregnant rat uterus and reached a maximum at delivery. These results suggested that a heightened level of contractile FP receptors and decreased relaxant EP 2 receptors may induce contraction for labor and allow birth to occur. Changes in the expression of isoforms of PG receptors in the rat uterus appear to be related to the changes in ovarian steroid concentration. The expression of EP 2 mRNA in the rat uterus was increased during pregnancy when circulating progesterone levels are elevated and decreased during labor, when circulating progesterone levels declined. Concomitantly, the expression of FP mRNA in the rat uterus was decreased during pregnancy, when circulating estrogen levels are relatively lower than during term labor [29] . The expression of FP receptor mRNA was increased during labor, when the estrogen levels are elevated. The similar pattern of changes in PG receptor isoforms in the rat uterus with circulating steroids reinforces our suggestion that these isoforms of PG receptors with opposing actions in myometrium, i.e., relaxant EP 2 and contractile FP receptor [7] , are regulated by steroid hormones. Moreover, our present investigation further demonstrated in the rat uterus that the expression of EP 2 mRNA was down-regulated by the antiprogesterone RU-486. On the other hand, the expression of FP mRNA was downregulated by the antiestrogen ICI 164384. As both progesterone and estrogen are essential for optimal uterine functions, synergistic as well as antagonistic effects of these steroids on PG receptor expression appear to be important for maintenance of pregnancy and the initiation of labor. The ratio of estrogens to progesterone levels changes at term, and we suggest that steroid hormone-induced changes in PG receptor subtypes may mediate the effects of steroid hormone on uterine contractility.
To assess the specific effects of estradiol and progesterone on PG receptors, we measured the expression of EP 2 and FP receptor mRNA in ovx rats treated with either estradiol, progesterone, or the combination of estradiol and progesterone. Similar to findings in the pregnant rats, uterine EP 2 receptor levels were elevated by progesterone, while estradiol had no effects. Furthermore, the FP receptor levels in the uterus were increased by estradiol, but pro-gesterone alone had no effects. This differential regulation of PG receptors in the uterus in nonpregnant rats was similar to changes in pregnant animals; i.e., EP 2 receptor expression was elevated in progesterone-treated ovx rats and in pregnant rats when progesterone levels are elevated, while FP receptors were increased with estradiol-17␤ in ovx rats and in pregnant rats at term labor when estrogen levels are elevated. Therefore, we suggest that steroid hormone effects are independent of pregnancy state and do not require fetal tissues.
We suggest from this study that the expression of relaxant EP 2 receptors in the rat uterus appeared to be progesterone dependent, while the contractile FP receptors appeared to be primarily estrogen dependent. In addition, progesterone appeared to antagonize the effects of estrogen on the FP receptor expression. This is supported by our observations that FP expression in the uterus of ovx rats was unchanged by progesterone, while estrogen-induced increase in FP expression is dampened by combined treatment with progesterone. However, the FP expression was significantly higher in the group treated with the combination of estrogen and progesterone than in oil-treated animals (Fig. 7) . Furthermore, in pregnant rat uterus, the RU-486-induced increase in FP expression (Fig. 6 ) may be through the removal of the inhibitory effect of progesterone on estrogen. These results indicate that progesterone may indirectly regulate FP receptor expression in the rat uterus via an inhibitory effect of progesterone on estrogen action or secretion [31] .
In summary, the results presented indicate distinct expression of EP 2 and FP receptor mRNA in the rat uterus during pregnancy and labor. Furthermore, each receptor showed progesterone-or estrogen-dependent changes in the levels of its expression, indicating hormonal regulation. Thus, it is suggested that PGs modulate uterine functions through at least two receptors: EP 2 is involved in relaxation, and FP is involved in myometrial contraction.
